Sanofi to work with Curie on ovarian cancer targets

06/20/2013 | GenomeWeb Daily News (free registration)

Sanofi and the Curie Institute have agreed to cooperate in the search for new therapeutic targets for ovarian cancer using next-generation sequencing, reverse-phase protein analysis and patient-derived xenografts. The three-year collaboration seeks "to gain a better understanding of the molecular alterations that characterize many types of ovarian cancer, thereby enabling effective new drugs to be designed," the partners said.

View Full Article in:

GenomeWeb Daily News (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director of Behavioral Health Operations
Meridian Health Plan
Detroit, MI
Medical Director
PacificSource
Bend, OR
Clinical Appeals RN
MJHS
Brooklyn, NY
Director of Clinical Operations
Meridian Health Plan
Detroit, MI
Sr. Director, Regulatory Compliance Intelligence and Outreach
Johnson & Johnson
New Brunswick, NJ